CAP1 and neoplasm: When the CAP1 protein phosphorylation rate between normal control and primary LUAD tumor samples was compared, it was observed that there was a higher protein phosphorylation rate in the NSCLC patient (Fig. 2e–g, datasets: NP_001099000.1: S255; Fig. 2h–j NP_001099000.1: S275).